Johnson & Johnson reaches deal with US government to lower drug prices
Jan 8 (Reuters) - Johnson & Johnson said on Thursday it has reached a agreement with U.S. President Donald Trump's administration to cut drug prices for Americans in exchange for exemptions from U.S. tariffs.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Sherry Jacob-Phillips)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The October Flush Is Over: Grayscale Says Deleveraging No Longer Pressuring Crypto Valuations
Crypto Users’ Reignite Interest in TRX Following an Impressive Rally
Germany warns social platforms over the spread of false AI holocaust images
Burnham’s high-rise property magnate receives £40m payout following government-backed loan
Trending news
MoreCrypto prices
More
